PAR 3.23% 30.0¢ paradigm biopharmaceuticals limited..

Breakthrough arthritis treatments will be available in five years, page-5

  1. 596 Posts.
    lightbulb Created with Sketch. 109
    Hi Mangoman 605.

    The article says they are in final stage clinical trials and recruiting, so it sounded more recent.
    Also, it says Andrew Walker commenced trials in 2016 and that 'the effect of the trial arthritis treatment lasted for almost six years' which takes it to 2022(?)

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $108.4M
Open High Low Value Volume
31.0¢ 31.5¢ 29.0¢ $118.7K 385.5K

Buyers (Bids)

No. Vol. Price($)
1 291 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 11136 4
View Market Depth
Last trade - 13.09pm 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.